Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
50
QDEL Quote, Financials, Valuation and Earnings
Last price:
$28.75
Seasonality move
:
4.22%
Day range:
$28.72 - $29.94
52-week range:
$19.50 - $49.45
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.74x
P/B ratio:
0.99x
Volume:
760.8K
Avg. volume:
1.3M
1-year change:
-33.52%
Market cap:
$2B
Revenue:
$2.8B
EPS (TTM):
-$17.02
Analysts' Opinion
-
Consensus RatingQuidelOrtho Corp. has received a consensus rating of Hold. The company's average rating is a Hold based on 2 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $37.67, QuidelOrtho Corp. has an estimated upside of 26.36% from its current price of $29.81.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $22.00 representing 100% downside risk from its current price of $29.81.
Fair Value
-
According to the consensus of 5 analysts, QuidelOrtho Corp. has 26.36% upside to fair value with a price target of $37.67 per share.
QDEL vs. S&P 500
-
Over the past 5 trading days, QuidelOrtho Corp. has overperformed the S&P 500 by 0.24% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
QuidelOrtho Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
QuidelOrtho Corp. revenues have been falling on a year-over-year basis for 9 quarters in a row. In the most recent quarter QuidelOrtho Corp. reported revenues of $700.5M.
Earnings Growth
-
QuidelOrtho Corp. earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter QuidelOrtho Corp. reported earnings per share of -$10.78.
Enterprise value:
4.8B
EV / Invested capital:
0.98x
Price / LTM sales:
0.74x
EV / EBIT:
42.67x
EV / Revenue:
1.76x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-31.16x
Price / Operating cash flow:
37.19x
Enterprise value / EBITDA:
8.66x
Gross Profit (TTM):
$1.1B
Return On Assets:
-17.88%
Net Income Margin (TTM):
-42.48%
Return On Equity:
-41.24%
Return On Invested Capital:
-20.79%
Operating Margin:
6.54%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $3.1B | $2.8B | $2.7B | $727.1M | $700.5M | |
| Gross Profit | $1.3B | $1.1B | $1.1B | $300.7M | $288.5M | |
| Operating Income | $284M | $99.4M | $111.8M | $52.1M | $45.8M | |
| EBITDA | $742.4M | $558.9M | $550.6M | $165.2M | $157.9M | |
| Diluted EPS | $0.19 | -$27.89 | -$17.02 | -$0.30 | -$10.78 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.1B | $1.4B | $1.4B | $1.4B | $1.4B | |
| Total Assets | $2.1B | $8.7B | $8.5B | $6.8B | $5.7B | |
| Current Liabilities | $297.1M | $872.7M | $860M | $1B | $767.9M | |
| Total Liabilities | $472.3M | $3.9B | $3.6B | $3.6B | $3.6B | |
| Total Equity | $1.6B | $4.8B | $5B | $3.2B | $2B | |
| Total Debt | $133.2M | $2.9B | $2.6B | $2.7B | $2.8B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $369.2M | $99.7M | $37M | $117.9M | -$45.5M | |
| Cash From Investing | -$191.8M | -$167.1M | -$181M | -$56.5M | -$53.9M | |
| Cash From Financing | -$239.7M | $59.9M | $98M | -$26.3M | $46M | |
| Free Cash Flow | $146.8M | -$96.8M | -$153.1M | $71.4M | -$94.7M | |
QDEL
Sector
Market Cap
$2B
$28.4M
Price % of 52-Week High
60.28%
51.17%
Dividend Yield
0%
0%
Shareholder Yield
-1.03%
-1.49%
1-Year Price Total Return
-33.52%
-16.67%
Beta (5-Year)
0.584
0.518
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$29.11
200-day SMA
Buy
Level
$28.59
Bollinger Bands (100)
Buy
Level
24.38 - 29.62
Chaikin Money Flow
Buy
Level
719.2K
20-day SMA
Buy
Level
$28.10
Relative Strength Index (RSI14)
Buy
Level
61.88
ADX Line
Buy
Level
9.51
Williams %R
Sell
Level
-15.0968
50-day SMA
Buy
Level
$26.54
MACD (12, 26)
Buy
Level
6.49
25-day Aroon Oscillator
Buy
Level
64
On Balance Volume
Neutral
Level
1.8M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.9393)
Buy
CA Score
(Annual)
Level (-0.2301)
Buy
Beneish M-Score
(Annual)
Level (-4.0824)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (1.2003)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
QuidelOrtho Corp. operates as a vitro diagnostics company. It is focused on developing and manufacturing diagnostic products. The company was founded on May 27, 2022 and is headquartered in San Diego, CA.
Stock Forecast FAQ
In the current month, QDEL has received 2 Buy ratings 3 Hold ratings, and 0 Sell ratings. The QDEL average analyst price target in the past 3 months is $37.67.
-
Where Will QuidelOrtho Corp. Stock Be In 1 Year?
According to analysts, the consensus estimate is that QuidelOrtho Corp. share price will rise to $37.67 per share over the next 12 months.
-
What Do Analysts Say About QuidelOrtho Corp.?
Analysts are divided on their view about QuidelOrtho Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that QuidelOrtho Corp. is a Sell and believe this share price will drop from its current level to $22.00.
-
What Is QuidelOrtho Corp.'s Price Target?
The price target for QuidelOrtho Corp. over the next 1-year time period is forecast to be $37.67 according to 5 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is QDEL A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for QuidelOrtho Corp. is a Hold. 3 of 5 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of QDEL?
You can purchase shares of QuidelOrtho Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase QuidelOrtho Corp. shares.
-
What Is The QuidelOrtho Corp. Share Price Today?
QuidelOrtho Corp. was last trading at $28.75 per share. This represents the most recent stock quote for QuidelOrtho Corp.. Yesterday, QuidelOrtho Corp. closed at $29.81 per share.
-
How To Buy QuidelOrtho Corp. Stock Online?
In order to purchase QuidelOrtho Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get QDEL Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
QDEL
Sector
P/E ratio
--
23.89x
PEG ratio
0.00x
-0.01x
P/B ratio
0.99x
1.81x
Price / LTM sales
0.74x
1.58x
Growth Metrics
QDEL
Sector
Revenue growth
-3.66%
4.62%
Earnings growth
-3545.38%
10.7%
Revenue (5-year growth)
39.1%
6.5%
Earnings forecast
$0.47
-$0.21
Profitability
QDEL
Sector
Profitability FY 2024
$1.1B
$3.6M
Return on invested capital
-20.79%
-31.84%
Return on assets
-17.88%
-27.96%
Return on equity
-41.24%
-37.63%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Feb
11
Estimated Next Earnings Date
Feb
4
Balance Sheet
QDEL
Sector
Total cash
$98.1M
$26.4M
Short term investments
--
$25.7M
Total assets
$7B
$76.9M
Long term debt
$2.8B
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 23
Applied Optoelectronics, Inc. [AAOI] is up 4.51% over the past day.
Buy
52
ABVX alert for Dec 23
Abivax SA [ABVX] is up 0.04% over the past day.
Buy
60
ZBIO alert for Dec 23
Zenas BioPharma, Inc. [ZBIO] is down 0.54% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
